Author

K. Safari

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell-cell communication· 1 Research Focus:clustering· 1 Approach:deep learning· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1

Frequent Co-Authors

A. Malovannaya· 1 shared A. Rivera-Tostado· 1 shared A. Saltzman· 1 shared A. Smith· 1 shared A. T. Szafran· 1 shared B. Zhang· 1 shared C. D. Candler· 1 shared C. Fan· 1 shared

Activity by Year

2023-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Malovannaya

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

SPACe (Swift Phenotypic Analysis of Cells): an open-source, single cell analysis of Cell Painting data

F. Stossi, P. K. Singh, M. Marini, K. Safari, A. T. Szafran, A. Rivera-Tostado, C. D. Candler, M. G. Mancini, E. A. Mosa, M. J. Bolt, D. Labate, M. A. Mancini

SPACe is an open-source tool for analyzing Cell Painting data, offering faster processing and better handling of cell-to-cell variation compared to existing software.

bioRxiv · Mar 21, 2024 · PreprintCell Biology

Targeting EIF4A triggers an interferon response to synergize with chemotherapy and suppress triple-negative breast cancer

N. Zhao, E. Kabotyanski, A. Saltzman, A. Malovannaya, X. Yuan, L. Reineke, N. Lieu, Y. Gao, D. Pedroza, S. Calderon, A. Smith, C. Hamor, K. Safari, S. Savage, B. Zhang, , J. Rosen

Zotatifin targets EIF4A to suppress TNBC by inhibiting Sox4, inducing interferon response, and reprogramming the tumor immune microenvironment, synergizing with chemotherapy.

bioRxiv · Sep 28, 2023Cancer Biology